Inhibitor Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2025, with ―. This bring the company's revenue in the last twelve months to -26.49K, Decreased 73.25%. In the fiscal year ending Dec 31, 2024, Inhibitor Therapeutics had annual revenue of 0.00 with ― growth.